Non-electric Intravenous Infusion Pump Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

The Global Non-electric Intravenous Infusion Pump Market was valued at USD 650 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 1 billion by 2035.

Growth across the non-electric intravenous infusion pump market for non-electric systems is supported by the increasing prevalence of long-term medical conditions and the rising number of surgical interventions worldwide. Healthcare providers are also increasingly looking for economical alternatives to electrically powered infusion devices, which is strengthening the demand for mechanical infusion technologies. Non-electric intravenous infusion pumps are compact medical devices designed to administer fluids and medications at controlled rates without the need for batteries or electrical power. Their design allows consistent delivery of therapeutic agents while maintaining operational simplicity. Demand is also rising due to the increasing need for continuous or extended drug administration outside conventional hospital settings. These systems are recognized for their portability, straightforward operation, and minimal maintenance requirements, making them well-suited for home healthcare programs and facilities with limited resources. Additionally, the ability of these pumps to support improved patient mobility and facilitate early discharge protocols has accelerated their acceptance in various clinical environments. The growing shift toward home-centered medical care is further strengthening the adoption of non-electric infusion technologies.

The elastomeric infusion pumps segment accounted for a substantial 85.7% share in 2025, driven by their practical design, portability, and dependable medication delivery capabilities. Elastomeric infusion pumps represent the most widely utilized category within the non-electric intravenous infusion pump industry because they provide continuous drug administration without requiring complex setup or electronic components. These devices rely on an elastic reservoir that gradually releases medication at a controlled rate, ensuring consistent therapy delivery. Their compact structure and silent functioning enhance convenience for patients and healthcare professionals, particularly in care environments where mobility and ease of use are essential.

The oncology application segment held a leading revenue share of 35.7% in 2025 and is projected to reach USD 388.9 million by 2035, owing to the increasing use of prolonged infusion therapies that require stable and controlled medication delivery. Non-electric infusion systems are widely utilized in oncology treatment programs because their portable design supports therapy administration beyond traditional hospital environments. The increasing global burden of cancer and the expansion of decentralized oncology care services are expected to continue driving demand for these infusion systems throughout the forecast period.

U.S. Non-electric Intravenous Infusion Pump Market generated USD 253.2 million in 2025, supported by high volumes of medical procedures, widespread use of ambulatory infusion therapies, and a well-developed home healthcare ecosystem. Favorable reimbursement frameworks and increasing reliance on outpatient care models continue to strengthen the adoption of these devices. Additionally, the presence of established manufacturers and growing familiarity among healthcare professionals with elastomeric infusion technologies are contributing to sustained demand across hospitals, outpatient facilities, and home-based treatment providers.

Key companies operating in the Global Non-electric Intravenous Infusion Pump Market include Baxter, B. Braun, AVANOS, Ambu, NIPRO, VYGON, Go Medical Industries, Technoline, Multimedical, and Epic. Companies participating in the Non-electric Intravenous Infusion Pump Market are implementing several strategic initiatives to strengthen their market position and expand global reach. Leading manufacturers are focusing heavily on research and development to improve device reliability, safety, and user convenience while maintaining cost efficiency. Many companies are also expanding their product portfolios with advanced infusion systems designed for broader therapeutic applications. Strategic partnerships with healthcare providers and distribution networks are helping organizations increase product accessibility in both developed and emerging healthcare markets. In addition, firms are prioritizing regulatory approvals and compliance with international healthcare standards to accelerate global market entry.